NPPB and pulmonary arterial hypertension: However, using a multicomponent improvement (MCI) index, a composite measure based on pre-specified improvements in functional class (FC), 6MWD and NT-proBNP, only 40% of patients responded to Sotatercept delivered in combination with background PAH therapy (Hoeper et al., 2023).